References
- Grayston J T, Kuo C C, Campbell L A, Wang S P. Chlamydia pneumoniae sp. nov. for Chlamydia sp. strain TWAR. Int J Syst Bact 1989; 39: 88–90
- Grayston J T, Campell L A, Kuo C C. A new respiratory tract pathogen: Chlamydia pneumoniae, strain TWAR. J Infect Dis 1990; 161: 618–25
- Hammarschlag M R, Chirgwin K, Roblin P M. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992; 14: 178–82
- Jackson L A, Rodriguez D I, Lee A, Kuo C C, Campbell L A, Grayston J T. Isolation of Chlamydia pneumoniae (TWAR) from a carotid atherosclerotic plaque speciment obtained by endarterectomy. Abstract of the 36th ICAAC. 1996; 272, (K121)
- Kuo C-C, Shor A, Campbell L A, Fukushi H, Patton D L, Grayston J T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841–9
- Ong G, Thomas B J, Mansfield A O, Davidson B R, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996; 49: 102–6
- Saikku P, Leinonen M, Tenkanen L. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Annals of Internal Medicine 1992; 116: 273–8
- Saikku P, Leinonen M, Mattila K, Ekman M R, Nieminen M S, Mäkelä P H. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983–6
- Saikku P. The epidemiology and significance of Chlamydia pneumoniae. Journal of Infection 25: Supplement 1992; 1: 27–34
- Saikku P. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J 1993; 14: 62–5, Suppl K: Dec
- Thom D H, Wang S P, Grayston J T. Chlamydia pneumoniae Strain TWAR antibody and angiographically demonstrated coronary artery disease. Arteriosclerosis and Trombosis 1991; 11: 547–1
- Thom D H, Grayston J T, Siscovick D S, Wang S P, Weiss N S, Dailing J R. Association of prior infection with C. pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68–72
- Weiss S M, Roblin M, Gaydos C A. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Inf Dis 1996; 173: 957–62
- Olsson M, Dalsgaard C-J, Haegerstrand A, Rosenqvist M, Rydén L, Nilsson J. Accumulation of T-lymphocytes and expression of interleukin-2 receptors in non-rheumatic stenotic aortic valves. J Am Coll Cardiol 1994; 23: 1164–70
- Otto C M, Kuusisto J, Reichenbach D D, Goun A M, O'Brien K D. Characterization of the early lesion of degenerative valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90(Aug (2)844–53
- Gaydos C A, Quinn T C, Eiden J J. Identification of Chlamydia pneumoniae by DNA amplification of the 16 S rRNA gene. J Clin Microbiol 1992; 30: 796–800
- Sanger F, Nicklen S, Coulson A R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463–7
- Hultman T, Ståhl S, Hornes E, Uhlen M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res 1989; 17: 4937–46
- Drancourt M, Mainardi J L, Brouqui P. Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med 1995; 332: 419–23
- Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–9
- Benditt E P, Barrett T G, McDougall J K. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci 1983; 80: 6386–9
- Melnick J L, Adam E, Debakey M E. Cytomegalovirus and atherosclerosis. Eur Heart J 1993; 14: 30–8, Suppl K
- Speir E, Modali R, Huang E S. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265(July 15)391–4
- Banks T A, Rouse B T. Herpesviruses – Immune Escape Artists?. Clin Infect Dis 1992; 14: 933–41
- Gaydos C, Summersgill J T, Sahney N N, Ramirez J A, Quinn T C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelium cells and aortic arthery smooth muscle cells. Infect Immunity 1996; 64: 1614–20
- Rothermel C D, Schachter J, Lavrich P, Lipsitz E C, Francus T. Chlamydia trachomatis-Induced production of interleukin-1 by. Human monocytes 1989; 57: 2705–11
- Dahlén G H, Boman J, Birgander L S, Lindblom B. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early çoronary artery disease. Atherosclerosis 1995; 114: 165–74
- Mautner G C, Mautner S L, Cannon R O, Hunsberger S A, Roberts W C. Clinical factors useful in predicting aortic valve structure in patients >40 years of age with isolated valvular aortic stenosis. Am J Cardiol 1993; 72: 194–8
- Nyström-Rosander C, Elfgren Å, Friman G, Hjelm E, Lindquist O, Påhlson C, Thelin S. Chlamydia pneumoniae påvisad med PCR-metodik i hjärtlelaffar vid operation av aortastenos. Svenska Läkaresállskepets Rikssfãmma, Samman-fattningar 1996; 1: 380
- Juvonen J, Laurila A, Juvonen T. Detection of Chlamydia pneumoniae in human non rheumatic stenotic aortic valves. J Am Coll Card 1997; 29(5)1054–59